Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Notable Labs Ltd (NTBL)

Notable Labs Ltd (NTBL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Notable Labs Ltd 320 HATCH DRIVE FOSTER CITY CA 94404 USA

www.notablelabs.com P: 415-851-2410

Description:

Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 1,510
Enterprise Value, $K -10,320
Shares Outstanding, K 2,220
Annual Sales, $ 310 K
Annual Net Income, $ -11,260 K
Last Quarter Sales, $ 310 K
Last Quarter Net Income, $ -6,680 K
EBIT, $ -14,380 K
EBITDA, $ -14,120 K
60-Month Beta 1.02
% of Insider Shareholders 1.20%
% of Institutional Shareholders 70.48%
Float, K 2,194
% Float 98.80%
Short Volume Ratio 0.58

Growth:

1-Year Return -92.38%
3-Year Return -99.13%
5-Year Return -98.33%
5-Year Revenue Growth -47.46%
5-Year Earnings Growth 84.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 05/15/24
Next Earnings Date 05/20/24
Earnings Per Share ttm -1.88
EPS Growth vs. Prev Year 59.96%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-35 on 10/17/23

NTBL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.54%
Return-on-Assets % -43.40%
Profit Margin % -3,632.26%
Debt/Equity 0.00
Price/Sales 6.37
Price/Cash Flow N/A
Price/Book 0.17
Book Value/Share 6.81
Interest Coverage -0.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar